- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01030887
PEACH Trial: Prescribed Exercise After Chemotherapy (PEACH)
Individually Prescribed Exercise Versus Usual Care in a Heterogeneous Cancer Survivor Population: A Pragmatic Randomized Controlled Trial
Many cancer survivors suffer symptoms such as fatigue and dyspnea which may persist for years or months after their chemotherapy has finished. Despite the known benefits of exercise and its potential to address many of the symptoms after cancer, the type of practical exercise programme which best suits this population is not known.
Many exercise programmes performed in cancer survivors take place over many weeks or months and include people with specific types of cancer. Such programmes may therefore not be suitable for the majority of cancer survivors and would pose serious practical difficulties with high drop-out rates and expensive resource consumption if they were extended into clinical practice.
We propose to run an 8-week exercise intervention in a mixed cancer population.
Hypothesis: A brief, individually tailored 8-week intervention will increase fitness and improve other physical symptoms in a mixed cancer survivor population after chemotherapy.
Aperçu de l'étude
Description détaillée
Background: Many cancer survivors suffer a range of physical and psychological symptoms with may persist for years or months after treatment finishes. Despite the known benefits of exercise and its potential to address many of these adverse effects of treatment, the role of exercise as well as its optimum duration, frequency, and intensity in this population has yet to be fully elucidated. Many cancer rehabilitation programmes presented in the literature are very long, have tight eligibility criteria and are not likely to be practical in the majority of cancer survivors. We plan to investigate a novel brief 8-week intervention which aims to increase physical fitness, and address other physical symptoms in a heterogeneous cancer survivor population.
Methods/design: Approximately 60 cancer survivors 2-6 months after completion of chemotherapy, usually adjuvant, with curative intent will be recruited through oncology clinics in a single institution and randomised to usual care or an exercise intervention. The exercise intervention consists of two specifically tailored, supervised, moderate intensity aerobic exercise sessions per week for 8 weeks. All participants will be assessed at baseline (0 weeks), post intervention (8 weeks), and at 3-month follow-up. The primary outcome measure is fitness, and secondary patient-related outcome measures include fatigue, quality of life, and morphological outcomes. A further secondary outcome is process evaluation including adherence to and compliance with the exercise program.
Discussion: This study will provide valuable information about the physical outcomes of this 8-week supervised aerobic programme. Additional process information and economic evaluation will inform the feasibility of implementing this program in a heterogeneous population after chemotherapy treatment with curative intent.
Type d'étude
Inscription (Réel)
Phase
- Phase 3
Contacts et emplacements
Lieux d'étude
-
-
-
Dublin, Irlande, 8
- Medical Oncology Department, St. James's Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Diagnosis of solid tumour and completion of adjuvant chemotherapy (and/or radiotherapy) with curative intent within the preceding 2-6 months. (Patients who have received neoadjuvant chemotherapy or chemoradiotherapy followed by surgery will also be eligible. In addition, patients continuing onto adjuvant hormone therapy and anti-Her2 directed therapy are eligible).
- Ability to understand English
- Willing to be randomised
- Medical clearance to exercise
- Age 21-69
- Fitness level average, fair or poor according to certain pre-determined cut-off points for age and gender(Fletcher et al., 2001)
- Willing and able to attend supervised exercise sessions twice weekly for a period of 8 weeks, with an intention of achieving > 90% attendance
- LVEF > 50% and not < 20% worse than baseline in applicable patients
Exclusion Criteria:
- Evidence of active cancer
- Chronic medical and orthopaedic conditions that would preclude exercise (eg uncontrolled congestive heart failure or angina, recent MI, breathing difficulties requiring oxygen use or hospitalization)
- On beta-blocker medication
- Prior history of another cancer in previous 5 years (exception: non-melanoma skin cancer and non-invasive cancer of the cervix)
- Confirmed pregnancy
- Dementia or psychiatric illness that would preclude ability to participate in study
- Incomplete haematological recovery after chemotherapy (WCC< 3, Hb < 10 or Platelets < 100)
- BMI > 35
- LVEF post chemotherapy < 50% or > 20% deterioration of baseline pre-systemic treatment. LVEF criteria are applicable in patients who have received chemotherapy deemed in normal clinical practice to have a potential effect LVEF and in whom the LVEF will have been measured before systemic treatment and at end of chemotherapy
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur actif: Exercise Programme
This will consist of an 8-week exercise programme, performed twice per week.
|
Moderate intensity exercise
|
Comparateur placebo: Usual Care
Standard practice including opportunistic exercise advice and patients' self-directed physical activity
|
Moderate intensity exercise
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Modified Bruce Treadmill Test (Fitness)
Délai: 0, 8 weeks, 3 months
|
0, 8 weeks, 3 months
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
FACT-G scale (Quality of life-overall)
Délai: 0, 8 weeks, 3 months
|
0, 8 weeks, 3 months
|
FACT-F (Fatigue)
Délai: 0, 8 weeks, 3 months
|
0, 8 weeks, 3 months
|
RT3 Accelerometry (Activity level)
Délai: 0, 8 weeks, 3 months
|
0, 8 weeks, 3 months
|
Tanita Body Fat Assessment (% fat)
Délai: 0, 8 weeks, 3 months
|
0, 8 weeks, 3 months
|
SF-36v2 (Quality of life-functional aspects)
Délai: 0, 8 weeks and 3 months
|
0, 8 weeks and 3 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Dearbhaile O' Donnell, MD, St. James's Hospital, Dublin, Ireland
- Chercheur principal: Juliette Hussey, PhD, Trinity College Dublin, Ireland
- Chercheur principal: Julie M Walsh, MSc, University of Dublin, Trinity College
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- CTPF/2008/12
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Exercise programme
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)Complété
-
Akdeniz UniversityPas encore de recrutementAVC ischémique | EncadrementTurquie
-
Johns Hopkins UniversityThe Rita and Alex Hillman Foundation; Abell Foundation; Richman Foundation; Sherman... et autres collaborateursRecrutementParentalité | Intervention parentaleÉtats-Unis
-
University of Texas Rio Grande ValleyHealth and Human Services Commission (HHSC); Pharr-San Juan-Alamo Independent... et autres collaborateursActif, ne recrute pasComportement lié à la santéÉtats-Unis
-
Children's HealthActif, ne recrute pasTroubles du spectre autistiqueÉtats-Unis
-
The University of Hong KongSydney Children's Hospitals Network; SAHKRecrutementTroubles du spectre autistiqueHong Kong
-
Hospices Civils de LyonRésilié
-
Microclinic InternationalRoyal Health Awareness Society (RHAS); Jordanian Ministry of Health (MoH)ComplétéHyperglycémie | Hypertension | Obésité | Diabète sucré, Type 2 | Diabète sucré | Diabète | Poids | Perte de poids | Pression artérielle | Gain de poids | Comportement social | Poids, Corps | Glycémie, hypertension | Mode de vie, Sain | Changement de poids, Corps | Comportement, Santé | Réduction des risques liés au mode... et d'autres conditionsJordan
-
Lady Davis InstituteComplétéSclérodermie systémiqueCanada
-
Bispebjerg HospitalAarhus University Hospital Skejby; Rigshospitalet, Denmark; Danish Cancer SocietyComplétéCancer | Arrêt du tabac | Tabagisme